Urteste S.A.

zł 41.00As of Sun 8 Nov 2026, 12:00 UTC
WSE:URTHealthcare
Country Poland
PE (Fwd) •••
TSR 5Y CAGR (15.76%)
Div yield —
ROE (16.02%)
Biotechnology
Beta (5Y) 0.20
PE TTM —
TSR TTM 44.37%
Mkt cap zł 62.57M
ROIC (9.37%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 45
9.56%
(1.65%)
Hold 8|6|1|7|11
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
0.56
0.56
0.62
0.62
(8.58%)
(7.97%)
1.43%
6.43%
Revenuezł M
6.778
6.984
7.058
7.352
8.93%
7.74%
7.03%
9.43%
Peers (US$15.80M)
Cap (US$)
PE
28.69M
—
24.17M
—
14.53M
112.3x
15.74M
—
Capital
TTM
5Y
10Y
Leveragex
2.709
0.921
0.854
EBIT/Intx
1.333
0.117
0.082
Own earn%
(13.81)
(24.80)
(49.02)
Sh yield%
13.47
13.98
15.28
Owners
Insiders/Inst%
14.54
44.78
Short interest%
5.70
SBC / revenue%
1.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
25–34
$1 testx
0.8
Incr. ROIC%
3